The clinical impact of different prophylactic anticoagulation regimens among hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. We pooled evidence from available randomized controlled trials (RCTs) to provide insights on this topic.

Matéria original

Anterior

Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel

Próxima

New-onset IgG autoantibodies in hospitalized patients with COVID-19